References
- 1. World Health Organization. Neglected tropical diseases; Snakebite [Internet]. 2009 [cited 2012 Apr 4]. Available from http://www.who.int/neglected_diseases/diseases/snakebites/en/
- 2. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008; 5:e218.10.1371/journal.pmed.0050218
- 3. Chanhome L, Cox MJ, Vasaruchapong T, Chaiyabutr N, Sitprija V. Characterization of venomous snakes of Thailand. Asian Biomed. 2011; 5:311-28.
- 4. Limthongkul S, Pochanugool C, Meemano K. Respiratory failure and its non-antivenin treatment in 37 adult neurotoxic snakes bite patients. In: Gophalakrishnakone P, Tan CK, editors. Progress in Venom and Toxic Research Singapore: National University of Singapore Press; 1987. p. 52-9.
- 5. Laothong C, Sitprija V. Decreased parasympathetic activities in Malayan krait (Bungarus candidus) envenoming. Toxicon. 2001; 39:1353-7.10.1016/S0041-0101(01)00087-3
- 6. Leeprasert W, Kaojarern S. Specific antivenom for Bungarus candidus. J Med Assoc Thai. 2007; 90: 1467-76.
- 7. Warrell DA, Looareesuwan S, White NJ, Theakston RD, Warrell MJ, Kosakarn W, et al. Severe neurotoxic envenoming by the Malayan krait Bungarus candidus (Linnaeus): response to antivenom and anticholinesterase. Br Med J (Clin Res Ed). 1983; 286:678-80.10.1136/bmj.286.6366.678
- 8. Warrell DA. Snake venoms in science and clinical medicine. 1. Russell’s viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg. 1989; 83:732-40.10.1016/0035-9203(89)90311-8
- 9. Rojnuckarin P. Snakebite-induced coagulopathy and bleeding disorders. In: Kini RM, Clemetson KJ, Markland FS, McLane MA, Morita T. Toxins and Hemostasis: From bench to bedside. Dordrecht: Springer. 2000, p. 699-710.
- 10. Mitrakul C, Impun C. The hemorrhagic phenomena associated with green pit viper (Trimeresurus erythrurus and Trimeresurus popeorum) bites in children. A report of studies to elucidate their pathogenesis. Clin Pediatr (Phila). 1973; 12:215-8.
- 11. Rojnuckarin P, Intragumtornchai T, Sattapiboon R, Muanpasitporn C, Pakmanee N, Khow O, et al. The effects of green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom on the fibrinolytic system in human. Toxicon. 1999; 37:743-55.10.1016/S0041-0101(98)00214-1
- 12. Mitrakul C. Effect of five Thai snake venoms on coagulation, fibrinolysis and platelet aggregation. Southeast Asian J Trop Med Public Health. 1979; 10: 266-75.
- 13. Warrell DA. Guidelines for the management of snakebite. New Delhi: WHO regional office for Southeast Asia; 2010.
- 14. Sano-Martins IS, Fan HW, Castro SC, Tomy SC, Franca FO, Jorge MT, et al. Reliability of the simple 20 minute whole blood clotting test (WBCT20) as an indicator of low plasma fibrinogen concentration in patients envenomed by Bothrops snakes. Butantan Institute Antivenom Study Group. Toxicon. 1994; 32: 1045-50.
- 15. Pongpit J, Limpawittayakul P, Juntiang J, Akkawat B, Rojnuckarin P. The role of prothrombin time (PT) in evaluating green pit viper (Cryptelytrops sp) bitten patients. Trans R Soc Trop Med Hyg. 2012; 106:415-8.10.1016/j.trstmh.2012.04.003
- 16. Ho M, Warrell DA, Looareesuwan S, Phillips RE, Chanthavanich P, Karbwang J, et al. Clinical significance of venom antigen levels in patients envenomed by the Malayan pit viper (Calloselasma rhodostoma). Am J Trop Med Hyg. 1986; 35:579-87.
- 17. Ribeiro LA, Jorge MT, Lebrão ML Prognostic factors for local necrosis in Bothrops jararaca (Brazilian pit viper) bites. Trans R Soc Trop Med Hyg. 2002; 95: 630-410.1016/S0035-9203(01)90101-4
- 18. Pugh RN, Theakston RD. Fatality following use of a tourniquet after viper bite envenoming. Ann Trop Med Parasitol. 1987; 81:77-8.10.1080/00034983.1987.11812097
- 19. Sutherland SK, Coulter AR, Harris RD. Rationalisation of first-aid measures for elapid snakebite Lancet. 1979; 1:183-5.
- 20. Norris RL, Ngo J, Nolan K, Hooker G. Physicians and lay people are unable to apply pressure immobilization properly in a simulated snakebite scenario. Wilderness Environ Med. 2005; 16:16-21.10.1580/PR12-04.1
- 21. Watt G, Padre L, Tuazon ML, Theakston RD, Laughlin LW. Tourniquet application after cobra bite: delay in the onset of neutotoxicity and dangers of sudden release. Am J Trop Med Hyg. 1998; 38:618-22.
- 22. Suankratay C, Wilde H, Nunthapisud P, Khantipong M. Tetanus after white-lipped green pit viper (Trimeresurus albolabris) bite. Wilderness Environ Med. 2002; 13:256-61.10.1580/1080-6032(2002)013[0256:TAWLGP]2.0.CO;2
- 23. Rojnuckarin P, Mahasandana S, Intragumtornchai T, Swasdikul D, Sutcharitchan P. Moderate to severe cases of green pit viper bites in Chulalongkorn hospital. J Hematol Transfus Med. 1996; 6:199-205.
- 24. Nuchprayoon I, Pongpan C, Sripaiboonkij N. The role of prednisolone in reducing limb oedema in children bitten by green pit vipers: a randomized, controlled trial. Ann Trop Med Parasitol. 2008; 102: 643-9.10.1179/136485908X311786
- 25. Rojnuckarin P, Mahasandana S, Intragumtornchai T, Sutcharitchan P, Swasdikul D. Prognostic factors of green pit viper bites. Am J Trop Med Hyg. 1998; 58: 22-5.
- 26. Rojnuckarin P, Banjongkit S, Chantawibun W, Akkawat B, Juntiang J, Noiphrom J. Pakmanee N, Intragumtornchai T. Green pit viper (Trimeresurus albolabris and T. macrops) venom antigenaemia and kinetics in humans. Trop Doct. 2007; 37:207-10.10.1258/004947507782332838
- 27. Archundia IG, de Roodt AR, Ramos-Cerrillo B, Chippaux JP, Olguín-Pérez L, Alagón A, et al. Neutralization of Vipera and Macrovipera venoms by two experimental polyvalent antisera: a study of paraspecificity. Toxicon. 2011; 57:1049-56.10.1016/j.toxicon.2011.04.009
- 28. Chotwiwatthanakun C, Pratanaphon R, Akesowan S, Sriprapat S, Ratanabanangkoon K. Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol. Toxicon. 2001; 39:1487-94.10.1016/S0041-0101(01)00108-8
- 29. Otero R, Gutiérrez JM, Rojas G, Núñez V, Díaz A, Miranda E, et al. A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon. 1999; 37:895-908.10.1016/S0041-0101(98)00220-7
- 30. Otero-Patiño R, Cardoso JL, Higashi HG, Nunez V, Diaz A, Toro MF, et al. A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. The Regional Group on Antivenom Therapy Research (REGATHER). Am J Trop Med Hyg. 1998; 58:183-9.
- 31. Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med. 2001; 37:196-201.10.1067/mem.2001.113134
- 32. Pochanugool C, Limthongkul S, Wilde H. Management of Thai cobra bites with a single bolus of antivenin. Wilderness Environ Med. 1997; 8:20-3.10.1580/1080-6032(1997)008[0020:MOTCBW]2.3.CO;2
- 33. Mitrakul C, Impun C. The hemorrhagic phenomena associated with green pit viper (Trimeresurus erythrus and Trimeresurus popeorum) bites in children. A report of studies in elucidate their pathogenesis. Clin Pediatr. 1973; 12:215-8.
- 34. Karnchanachetanee C, Hanvivatvong O, Mahasandana S Monospecific antivenin therapy in Russell´s viper bite. J Med Assoc Thai. 1994; 77:293-7.
- 35. Mitrakul C. Juzi U, Pongrujikorn W. Antivenom therapy in Russell’s viper bite. Am J Clin Pathol. 1991; 95:412-7.10.1093/ajcp/95.3.412
- 36. Hung DZ, Yu YJ, Hsu CL, Lin TJ. Antivenom treatment and renal dysfunction in Russell’s viper snakebite in Taiwan: a case series. Trans R Soc Trop Med Hyg. 2006; 100:489-94.10.1016/j.trstmh.2005.07.020
- 37. Rojnuckarin P, Chanthawibun W, Noiphrom J, Pakmanee N, Intragumtornchai T. A randomized, double blind, placebo-controlled trial of antivenom for local effects of green pit viper bites. Trans R Soc Trop Med Hyg. 2006; 100:879-84. 10.1016/j.trstmh.2005.10.006
- 38. Chotenimitkhun R, RojnuckarinP. Systemic Antivenom and Skin Necrosis after Green Pit Viper Bites. Clin Toxicol. 2008; 46:122-5.10.1080/15563650701266826
- 39. Gutiérrez JM, León G, Rojas G, Lomonte B, Rucavado A, Chaves F. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. Toxicon. 1998; 36:1529-38.10.1016/S0041-0101(98)00145-7
- 40. Thiansookon A, Rojnuckarin P. Low Incidence of Early Reactions to Horse-derived F(ab’)2 Antivenom for Snakebites in Thailand. Acta Trop. 2008; 105:203-5.10.1016/j.actatropica.2007.09.007
- 41. Isbister GK, Brown SG, MacDonald E, White J, Currie BJ; Australian Snakebite Project Investigators. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust. 2008; 188:473-6.
- 42. Malasit P, Warrell DA, Chanthavanich P, Viravan C, Mongkolsapaya J, Singhthong B, et al. Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites. BMJ. 1986; 292:17-20.10.1136/bmj.292.6512.17
- 43. Otero R, León G, Gutiérrez JM, Rojas G, Toro MF, Barona J, et al. Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans R Soc Trop Med Hyg. 2006; 100:1173-82.10.1016/j.trstmh.2006.01.006
- 44. Premawardhena AP, de Silva CE, Fonseka MM, Gunatilake SB, de Silva HJ. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. BMJ. 1999; 17: 1041-3.10.1136/bmj.318.7190.1041
- 45. de Silva HA, Pathmeswaran A, Ranasinha CD, Jayamanne S, Samarakoon SB, Hittharage A, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011; 8:e1000435.10.1371/journal.pmed.1000435
- 46. Gawarammana IB, Kularatne SA, Dissanayake WP, Kumarasiri RP, Senanayake N, Ariyasena H. Parallel infusion of hydrocortisone +/- chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. Med J Aust. 2004; 180:20-3.
- 47. Fan HW, Marcopito LF, Cardoso JL, França FO, Malaque CM, Ferrari RA, et al. Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. BMJ. 1999; 29:1451-2.10.1136/bmj.318.7196.1451
- 48. Isbister GK, Shahmy S, Mohamed F, Abeysinghe C, Karunathilake H, Ariaratnam A. A randomised controlled trial of two infusion rates to decrease reactions to antivenom. PLoS One. 2012; 7:e38739.
- 49. Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002; 347:347-56.10.1056/NEJMra013477
- 50. Jorge MT, Malaque C, Ribeiro LA, Fan HW, Cardoso JL, Nishioka SA, et al. Failure of chloramphenicol prophylaxis to reduce the frequency of abscess formation as a complication of envenoming by Bothrops snakes in Brazil: a double-blind randomized controlled trial. Trans R Soc Trop Med Hyg. 2004; 98:529-34.10.1016/j.trstmh.2003.12.009
- 51. Pongprasit P, Mitrakul C, Nopadon N. Histopathology and microbiological study of cobra bite wounds. J Med Assoc Thai. 1988; 71:475-80.
- 52. Theakston RD, Phillips RE, Looareesuwan S, Echeverria P, Makin T, Warrell DA Bacteriological studies of the venom and mouth cavities of wild Malayan pit vipers (Calloselasma rhodostoma) in Southern Thailand. Trans R Soc Trop Med Hyg. 2002; 84:875-9.